Published in J Virol on February 01, 1994
The RGG box motif of the herpes simplex virus ICP27 protein mediates an RNA-binding activity and determines in vivo methylation. J Virol (1996) 2.35
Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J Virol (1997) 2.27
Identification of nuclear and nucleolar localization signals in the herpes simplex virus regulatory protein ICP27. J Virol (1995) 1.85
ICP27 recruits Aly/REF but not TAP/NXF1 to herpes simplex virus type 1 transcription sites although TAP/NXF1 is required for ICP27 export. J Virol (2005) 1.77
Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol (1996) 1.61
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Mta has properties of an RNA export protein and increases cytoplasmic accumulation of Epstein-Barr virus replication gene mRNA. J Virol (1998) 1.46
Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J Virol (2001) 1.38
Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27. J Virol (1997) 1.38
Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA. J Virol (1995) 1.32
Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways. J Virol (2000) 1.32
Hsc70 focus formation at the periphery of HSV-1 transcription sites requires ICP27. PLoS One (2008) 1.23
Efficient nuclear export of herpes simplex virus 1 transcripts requires both RNA binding by ICP27 and ICP27 interaction with TAP/NXF1. J Virol (2008) 1.19
Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J Virol (2005) 1.15
Regulatory function of the equine herpesvirus 1 ICP27 gene product. J Virol (1995) 1.12
Direct stimulation of translation by the multifunctional herpesvirus ICP27 protein. J Virol (2006) 1.11
Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated alpha-globin pre-mRNA in infected HeLa cells. J Virol (2000) 1.06
Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells. J Virol (2001) 1.05
The role of herpes simplex virus ICP27 in the regulation of UL24 gene expression by differential polyadenylation. J Virol (1998) 1.05
SR proteins SRp20 and 9G8 contribute to efficient export of herpes simplex virus 1 mRNAs. Virology (2010) 1.04
Processing of alpha-globin and ICP0 mRNA in cells infected with herpes simplex virus type 1 ICP27 mutants. J Virol (2000) 1.04
Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB. J Virol (2006) 1.03
Multiple roles of Epstein-Barr virus SM protein in lytic replication. J Virol (2007) 0.99
Transactivation of a viral target gene by herpes simplex virus ICP27 is posttranscriptional and does not require the endogenous promoter or polyadenylation site. J Virol (2003) 0.98
Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II. J Virol (2005) 0.98
Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene. J Virol (2006) 0.97
Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Res (2009) 0.97
Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup62, inhibiting host nucleocytoplasmic transport pathways. J Biol Chem (2012) 0.94
Herpes simplex virus type 1 immediate-early protein ICP27 is required for efficient incorporation of ICP0 and ICP4 into virions. J Virol (2007) 0.94
The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infections. J Virol (2002) 0.94
CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 protein. J Virol (2003) 0.94
Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism. J Virol (2008) 0.90
UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture. J Virol (2006) 0.88
Nucleocytoplasmic shuttling of human cytomegalovirus UL84 is essential for virus growth. J Virol (2010) 0.84
Identification of an ICP27-responsive element in the coding region of a herpes simplex virus type 1 late gene. J Virol (2009) 0.82
Role of immediate early protein ICP27 in the differential sensitivity of herpes simplex viruses 1 and 2 to leptomycin B. J Virol (2013) 0.78
The structure of the folded domain from the signature multifunctional protein ICP27 from herpes simplex virus-1 reveals an intertwined dimer. Sci Rep (2015) 0.77
The conserved carboxyl-terminal half of herpes simplex virus type 1 regulatory protein ICP27 is dispensable for viral growth in the presence of compensatory mutations. J Virol (2000) 0.76
Functional comparison of herpes simplex virus 1 (HSV-1) and HSV-2 ICP27 homologs reveals a role for ICP27 in virion release. J Virol (2014) 0.76
Nuclear export of VP19C is not essential for replication of herpes simplex virus type 1. Cell Biosci (2014) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol (1974) 26.25
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol (1979) 11.34
A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature (1980) 8.47
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol (1985) 6.67
Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA. J Virol (1980) 5.69
Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol (1981) 5.66
Primary structure of the herpesvirus saimiri genome. J Virol (1992) 5.26
Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem (1992) 4.84
Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol (1983) 4.56
Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol (1984) 4.37
The DNA sequence of equine herpesvirus-1. Virology (1992) 4.36
Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol (1989) 4.18
Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol (1990) 3.63
A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing. Genes Dev (1992) 3.44
The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J Virol (1988) 3.33
Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc Natl Acad Sci U S A (1986) 3.28
Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology (1992) 3.27
The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans. J Gen Virol (1986) 3.15
Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27. J Virol (1988) 3.08
Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus. J Virol (1982) 2.99
Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation. J Virol (1975) 2.92
The DNA-binding properties of the major regulatory protein alpha 4 of herpes simplex viruses. Science (1988) 2.69
Deletion of the VP16 open reading frame of herpes simplex virus type 1. J Virol (1992) 2.50
Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J Virol (1989) 2.35
Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing. J Virol (1992) 2.29
Adenovirus E1A protein paradigm viral transactivator. Annu Rev Genet (1989) 2.23
Genetic relations between varicella-zoster virus and Epstein-Barr virus. J Gen Virol (1987) 2.17
Characterization of the large tegument protein (ICP1/2) of herpes simplex virus type 1. Virology (1992) 2.14
Mutational dissection of the HSV-1 immediate-early protein Vmw175 involved in transcriptional transactivation and repression. Virology (1988) 2.03
Herpes simplex virus alpha protein ICP27 can inhibit or augment viral gene transactivation. Virology (1989) 1.99
The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule. J Virol (1989) 1.99
Mutations in the major DNA-binding protein gene of herpes simplex virus type 1 result in increased levels of viral gene expression. J Virol (1983) 1.98
The acidic amino-terminal region of herpes simplex virus type 1 alpha protein ICP27 is required for an essential lytic function. J Virol (1993) 1.59
Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activities. J Virol (1989) 1.59
Characterization of the DNA-binding properties of herpes simplex virus regulatory protein ICP4. J Virol (1989) 1.51
Promoter-independent activation of heterologous virus gene expression by the herpes simplex virus immediate-early protein ICP27. Virology (1992) 1.22
Identification and transcriptional analyses of the UL3 and UL4 genes of equine herpesvirus 1, homologs of the ICP27 and glycoprotein K genes of herpes simplex virus. J Virol (1992) 1.21
A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties. J Virol (1991) 1.19
Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant. J Virol (1991) 1.14
Herpes simplex virus type 1 alpha gene containing plasmids can inhibit expression regulated from an alpha promoter in CV-1 but not HeLa cells. Virus Res (1988) 1.03
Intragenic complementation of herpes simplex virus ICP8 DNA-binding protein mutants. J Virol (1993) 0.99
Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol (1996) 2.25
Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J Virol (1995) 2.13
RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J Virol (1994) 2.12
Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity (2001) 2.11
Identification of nuclear and nucleolar localization signals in the herpes simplex virus regulatory protein ICP27. J Virol (1995) 1.85
The acidic amino-terminal region of herpes simplex virus type 1 alpha protein ICP27 is required for an essential lytic function. J Virol (1993) 1.59
Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Ann Surg (1983) 1.55
Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss. J Bone Miner Res (2001) 1.21
Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J Biol Chem (1997) 1.11
The role of SHIP in cytokine-induced signaling. Rev Physiol Biochem Pharmacol (2003) 1.06
SHIPs ahoy. Int J Biochem Cell Biol (1999) 1.04
Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages. Biochem Soc Trans (2003) 1.00
The role of SHIP1 in macrophage programming and activation. Biochem Soc Trans (2004) 0.96
Potential benefits of single-port compared to multiport laparoscopic inguinal herniorraphy: a prospective randomized controlled study. Hernia (2014) 0.95
Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg (2009) 0.94
Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk. Prog Lipid Res (2009) 0.94
Transforming growth factor beta 1 is an inducer of erythroid differentiation. J Exp Med (1994) 0.94
Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin. J Biol Chem (1996) 0.93
Quantifying viral propagation in vitro: toward a method for characterization of complex phenotypes. Biotechnol Prog (2001) 0.93
An integrated YAC map of the human X chromosome. Genome Res (1996) 0.93
Suggested specifications for a standardized Addiction Severity Index database. J Subst Abuse Treat (2001) 0.93
Aging-related changes in blood-brain barrier integrity and the effect of dietary fat. Neurodegener Dis (2012) 0.92
Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules. Hum Immunol (1989) 0.88
Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIalpha expression. Biochem Pharmacol (2001) 0.88
Functional analysis of the cis-acting elements responsible for the induction of the Cyp6a8 and Cyp6g1 genes of Drosophila melanogaster by DDT, phenobarbital and caffeine. Insect Mol Biol (2009) 0.86
Using formal concept analysis for microarray data comparison. J Bioinform Comput Biol (2008) 0.84
Vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in Chinese men and women. Osteoporos Int (2002) 0.84
Studies on protein phosphorylation using subcellular fractions from insulin-treated white adipose tissue of rats. Biochem Cell Biol (1988) 0.83
Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations. Leukemia (2013) 0.83
Uneven gas mixing during rebreathing assessed by simultaneously measuring dead space. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.81
The role of the SRC homology 2-containing inositol 5'-phosphatase in Fc epsilon R1-induced signaling. Curr Top Microbiol Immunol (1999) 0.80
A specific in vitro bioassay for measuring erythropoietin levels in human serum and plasma. Blood (1990) 0.80
Study of potency, kinetics of block and toxicity of NMDA receptor antagonists using fura-2. Eur J Pharmacol (1996) 0.79
Adrenaline-induced desensitization of liver adenylate cyclase. Biochem Pharmacol (1976) 0.77
Estrogen receptor gene polymorphism and bone mineral density in postmenopausal Chinese women. Bone (2001) 0.77
Phenotype-genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling. Diabetologia (2009) 0.77
Monitoring hemangioblastoma tumor burden using plasma erythropoietin levels. Int J Hematol (1992) 0.75
Biophysical mechanism of the scavenger site near T cell-presented epitopes. Vaccine (1992) 0.75
Effect of acute hypoxia on airway and vascular exchangeable lung water spaces in dogs. Am Rev Respir Dis (1984) 0.75
Single-incision laparoscopic inguinal herniorraphy with telescopic extraperitoneal dissection: technical aspects and potential benefits. Hernia (2015) 0.75
Application of a silver-binding assay to the determination of protein in cerebrospinal fluid. Clin Chem (1989) 0.75
C.T. findings of orbital inflammation in children. Australas Radiol (1987) 0.75